Reiberger T - Search Results

1

Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis.

Simbrunner B, Semmler G, Stadlmann A, Scheiner B, Schwabl P, Paternostro R, Bucsics T, Bauer D, Eigenbauer E, Pinter M, Stättermayer AF, Quehenberger P, Marculescu R, Trauner M, Mandorfer M, Reiberger T. Simbrunner B, et al. Among authors: reiberger t. Hepatol Int. 2020 Dec;14(6):1093-1103. doi: 10.1007/s12072-020-10112-3. Epub 2020 Dec 8. Hepatol Int. 2020. PMID: 33289910 Free PMC article.

2

Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.

Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M. Angermayr B, et al. Among authors: reiberger t. Eur J Clin Invest. 2009 Jan;39(1):65-71. doi: 10.1111/j.1365-2362.2008.02063.x. Eur J Clin Invest. 2009. PMID: 19087131

3

Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.

Reiberger T, Angermayr B, Schwabl P, Rohr-Udilova N, Mitterhauser M, Gangl A, Peck-Radosavljevic M. Reiberger T, et al. J Hepatol. 2009 Nov;51(5):865-73. doi: 10.1016/j.jhep.2009.06.024. Epub 2009 Aug 4. J Hepatol. 2009. PMID: 19726100

4

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.

Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M. Reiberger T, et al. J Viral Hepat. 2010 Jun;17(6):400-9. doi: 10.1111/j.1365-2893.2009.01197.x. Epub 2009 Sep 15. J Viral Hepat. 2010. PMID: 19780945

5

Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection.

Reiberger T, Rutter K, Ferlitsch A, Payer BA, Hofer H, Beinhardt S, Kundi M, Ferenci P, Gangl A, Trauner M, Peck-Radosavljevic M. Reiberger T, et al. Clin Gastroenterol Hepatol. 2011 Jul;9(7):602-8.e1. doi: 10.1016/j.cgh.2011.03.002. Epub 2011 Mar 10. Clin Gastroenterol Hepatol. 2011. PMID: 21397726

6

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study.

Pinter M, Sieghart W, Reiberger T, Rohr-Udilova N, Ferlitsch A, Peck-Radosavljevic M. Pinter M, et al. Among authors: reiberger t. Aliment Pharmacol Ther. 2012 Jan;35(1):83-91. doi: 10.1111/j.1365-2036.2011.04896.x. Epub 2011 Oct 27. Aliment Pharmacol Ther. 2012. PMID: 22032637 Free article.

7

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab. Reiberger T, et al. J Gastroenterol. 2012 May;47(5):561-8. doi: 10.1007/s00535-011-0517-4. Epub 2011 Dec 15. J Gastroenterol. 2012. PMID: 22170417

8

von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Ferlitsch M, et al. Among authors: reiberger t. Hepatology. 2012 Oct;56(4):1439-47. doi: 10.1002/hep.25806. Epub 2012 Aug 27. Hepatology. 2012. PMID: 22532296

9

Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Schwabl P, Stift J, Trauner M, Peck-Radosavljevic M. Reiberger T, et al. Wien Klin Wochenschr. 2012 Jun;124(11-12):395-402. doi: 10.1007/s00508-012-0190-5. Epub 2012 Jun 15. Wien Klin Wochenschr. 2012. PMID: 22699260

10

A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.

Reiberger T, Payer BA, Ferlitsch A, Sieghart W, Breitenecker F, Aichelburg MC, Schmied B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab and Vienna HIV & Liver Study Group. Reiberger T, et al. Antivir Ther. 2012;17(7):1327-34. doi: 10.3851/IMP2349. Epub 2012 Sep 5. Antivir Ther. 2012. PMID: 22948263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page